<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03789526</url>
  </required_header>
  <id_info>
    <org_study_id>REC-AFMG 2018/6</org_study_id>
    <nct_id>NCT03789526</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus</brief_title>
  <official_title>Ultrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al-Azhar University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Al-Azhar University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluates the efficacy of ultrasound guided versus clinically guided steroid injection in the
      management of tenosynovitis in DM patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current study will based on follow up study, conducted among patients presenting at
      outpatient rheumatology clinics of Al-Azhar University Hospitals, Egypt. with Diabetes
      mellitus duration at least 3 years and tenosynovitis of hand tendons with Richie tenderness
      grade 3.

      All patients will randomized in two groups: Group one: 26 patients DM patients with
      tenosynovitis were injected by triamcinolone under ultrasound guidance. Group two: 26
      patients DM patients with tenosynovitis were injected by triamcinolone under clinical
      guidance.

      The affected tendons will scanned and scored for inflammation using ultrasound in all
      patients before the triamcinolone injection and then to be reassessed one month after the
      injection to determine the change in the tendons in both groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 11, 2018</start_date>
  <completion_date type="Actual">February 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance.
Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in Tenosynovitis pain</measure>
    <time_frame>one month</time_frame>
    <description>changes in VAS scale for pain,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in Tenosynovitis tenderness</measure>
    <time_frame>one month</time_frame>
    <description>changes in Richie index for tenderness.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in ultrasound images of the Tenoasynovitis.</measure>
    <time_frame>one month</time_frame>
    <description>changes in Gery scale images, and power Doppler images of the tendons</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Ultrasound Guided Injection</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound guidance</intervention_name>
    <description>ultrasound guidance of tendon injection</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Diabetes mellitus.

               -  Disease duration 3 years or more.

               -  Tenosynovitis of hand tendons with Richie tenderness grade 3.

        Exclusion Criteria:

          -  • Patients with recent hand trauma.

               -  Patients with inflammatory hand arthritis.

               -  Previous tendon surgery.

               -  Previous tendon injection.

               -  Patients with contraindication for injection as related infection, uncontrolled
                  DM or bleeding tendency.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Al-Azhar university hospitals</name>
      <address>
        <city>Cairo</city>
        <zip>11311</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>December 24, 2018</study_first_submitted>
  <study_first_submitted_qc>December 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2018</study_first_posted>
  <last_update_submitted>June 10, 2019</last_update_submitted>
  <last_update_submitted_qc>June 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Al-Azhar University</investigator_affiliation>
    <investigator_full_name>Ahmed Abogamal</investigator_full_name>
    <investigator_title>clinical professor of Rheumatology</investigator_title>
  </responsible_party>
  <keyword>Tenosynovitis</keyword>
  <keyword>ultrasound</keyword>
  <keyword>diabetes mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tenosynovitis</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

